This translation may be used only for reference purposes. This English version is not an official translation of the original Japanese document. In cases where any differences occur...
Adlai Nortye filed for $72M IPO for its cancer drug development with a candidate in advanced stages of trials and solid financials. Learn more on ANL stock here.
Adlai Nortye Ltd. has filed to raise $115 million in a U.S. IPO, although the final figure may differ. Click for my first look at the ANL IPO and its prospects.
Reactive Dyes Market Research Report Information By Type (Reactive Cold Dyes, Reactive Hot Dyes, Reactive HE Dyes, Reactive ME Dyes, and Others), By...
Global blood testing market growth is driven by growing concerns about viruses and chronic diseases. In 2021, North America held the largest share of the...
Reactive Dyes Market Insights and Industry Analysis by Types (Reactive Cold Dyes, Reactive Hot Dyes, Reactive 'HE' Dyes, Reactive 'ME' Dyes, and Others),...